2022-RA-603-ESGO The effect of oral metronomic chemotherapy on reccurrent progressive ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

2022-RA-603-ESGO The effect of oral metronomic chemotherapy on reccurrent progressive ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: October 2022 to October 2024

	Abstract	Full	Pdf
Oct 2022	4	0	4
Nov 2022	29	0	4
Dec 2022	44	0	9
Jan 2023	16	0	1
Feb 2023	16	0	2
Mar 2023	38	0	6
Apr 2023	18	0	1
May 2023	16	0	2
Jun 2023	33	0	6
Jul 2023	40	0	4
Aug 2023	43	0	7
Sep 2023	27	0	6
Oct 2023	18	0	1
Nov 2023	18	0	3
Dec 2023	19	0	3
Jan 2024	22	0	1
Feb 2024	22	0	6
Mar 2024	30	0	4
Apr 2024	10	0	5
May 2024	26	0	5
Jun 2024	23	0	3
Jul 2024	34	0	3
Aug 2024	16	0	4
Sep 2024	18	0	1
Oct 2024	11	0	1
Total	591	0	92